Wednesday, 12 March 2025
  
Login

Australia's most trusted
source of pharma news

Wednesday, 12 March 2025
News

Three brands hit with first generic

Posted 10 March 2025 AM 

Competition has heated up for Novo Nordisk, Merck Healthcare, and Mayne Pharma with the TGA approving the first generic versions of their medicines last week along with a new prescription vitamin D supplement.

Sun Pharma registered the first copycat of Novo Nordisk’s GLP-1 receptor agonists Saxenda and Victoza under three brands – Benedo, Liraglutide RBX, and Liraglutide Sun.

To see the whole article, please login

Popular

40-year-old pharma rebrands
Which Aussie pharma pays most?
Three brands hit with first generic
Amid job cuts, boss trims pay
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (37)

Clinical & Medical, R&D (16)

Regulatory, Pharmacovigilance & QA (1)

Other (17)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home